SEC Tracker
Get the app

Ardelyx ARDX

Ardelyx, Inc. announced its financial results for the quarter ended June 30, 2023.

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Ardelyx files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  2. CorMedix CRMD public float $910M, Jun 30, 2025
  3. Viridian Therapeutics VRDN public float $943M, Jun 30, 2025
  4. Akebia Therapeutics AKBA public float $946M, Jun 30, 2025
  5. Neogen NEOG public float $972M, Nov 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.